Category: Treatment News
-
Orphan Drug New Immunotherapy Treatment
Another pharmaceutical company is dedicating resources to help find an effective treatment for mesothelioma. Its efforts have led to an Orphan Drug Designation from the U.S. Food and Drug Administration, and comes on the heels of CRS-207 and tremelimumab, two other drugs developed to make a difference for mesothelioma patients, receiving the same designation from …
Label: Treatment News
Posted on Thursday, Sep 17, 2015
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.